Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program
07 sept. 2023 07h30 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly...
Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing
05 sept. 2023 07h30 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation...
Optimi Health Announces CAD $3,000,000 Senior Debt Financing
10 août 2023 07h30 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian drug research and formulation company licensed by Health Canada...
Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent
01 août 2023 07h30 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
MRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Exhibiting Numerous Medicinal Health Benefits
17 juil. 2023 09h51 HE
|
Institute of Biomedical Research Corp.
CAPE TOWN, South Africa, July 17, 2023 (GLOBE NEWSWIRE) -- via IBN -- Institute of Biomedical Research Corp. (OTC PINK: MRES) (“Institute of Biomedical Research” or the "Company"), a nutraceutical...
Cortexa Makes First Drug Order for Australian Commercial Market
04 juil. 2023 08h55 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, July 04, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS
15 juin 2023 09h40 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
World Renowned International Psychedelics Experts Join Clarion Clinics Advisory Board
30 mai 2023 08h00 HE
|
Incannex Healthcare
Highlights: Three world-leading clinical psychedelics experts join Clarion Clinics Advisory Board.Dr. Bill Richards is among the world’s best known psychedelic researchers and practitioners. He has...
Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market
17 mai 2023 08h15 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
PharmAla Biotech and Shaman Pharma Granted First Ever Special Access Program Authorization for MDMA
16 mai 2023 11h37 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, May 16, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and manufacturing...